The 20 Best Hereditary Resistance to Anti-Vitamin K Doctors Near Me in New Jersey, US

Gregory Shypula is a Hematologist Oncology provider practicing medicine in Edison, New Jersey. Dr. Shypula is rated as a Distinguished provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Protein C Deficiency, Congenital Antithrombin 3 Deficiency, Protein S Deficiency, Gastrostomy, and Endoscopy. Dr. Shypula is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine.

Charlesse Pondt-Huannou, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, she has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Pondt-Huannou is dedicated to providing the highest quality of care for her patients. She listens thoroughly and takes time to carefully explain everything involved in the patient’s individualized plan of care.Dr. Pondt-Huannou is an expert in the fields of breast and gynecological cancers; hematologic malignancies (myeloma and chronic leukemias and lymphomas); managing complex hematological issues in high-risk obstetric and gynecologic patients; sickle cell disease; and anemia. She is also experienced in the management of liver, bladder, colon, cervical, lung, prostate and pancreatic cancers. She joined ACOHA immediately out of fellowship in 2014.After earning her medical degree from UMDNJ New Jersey Medical School in Newark, NJ, Dr. Pondt-Huannou completed an internal medicine residency at Memorial Sloan-Kettering Cancer Center concurrent with a residency at New York-Presbyterian, Cornell Medical Center, both in New York City. She completed a hematology and oncology fellowship at Albert Einstein College/Montefiore and Jacobi medical centers and Lincoln Hospital in the Bronx, NY.Dr. Pondt-Huannou is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Medical Association, and the National Medical Association. She also serves on numerous committees including the Sickle Cell Management Committee at Overlook Medical Center. She is a participating provider of the Atlantic Accountable Care Organization. Dr. Huannou is rated as an Advanced provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Childhood Iron Deficiency Anemia, Anemia, Deep Vein Thrombosis, and Myelodysplastic Syndrome (MDS). Dr. Huannou is board certified in American Board Of Internal Medicine. Dr. Huannou is currently accepting new patients.

Bernard Kulper is a Hematologist practicing medicine in Avenel, New Jersey. Dr. Kulper is rated as a Distinguished provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Protein C Deficiency, Congenital Antithrombin 3 Deficiency, Hereditary Resistance to Anti-Vitamin K, Pacemaker Implantation, and Ureteroscopy.

Tomasz Grochowalski is a primary care provider, practicing in Internal Medicine in South Amboy, New Jersey. Dr. Grochowalski is rated as a Distinguished provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Protein S Deficiency, Protein C Deficiency, Congenital Antithrombin 3 Deficiency, and Hereditary Resistance to Anti-Vitamin K. Dr. Grochowalski is board certified in American Board Of Internal Medicine.

Kelly Fitzpatrick is an Oncologist and a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Fitzpatrick is rated as an Advanced provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Primary Mediastinal B-Cell Lymphoma (PMBCL), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Congenital Antithrombin 3 Deficiency, and Bone Marrow Aspiration. Dr. Fitzpatrick is board certified in American Board Of Internal Medicine and Internal Medicine.

Paul Chung is a Hematologist Oncology provider practicing medicine in Manahawkin, New Jersey. Dr. Chung is rated as an Advanced provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. He is also highly rated in 59 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Multiple Myeloma, Lung Cancer, Familial Pancreatic Cancer, and Bone Marrow Aspiration. Dr. Chung is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine.

Michael Levitt is a Hematologist Oncology provider practicing medicine in Neptune, New Jersey. Dr. Levitt is rated as an Advanced provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. He is also highly rated in 51 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Small Cell Lung Cancer (SCLC), Bone Marrow Aspiration, and Endoscopy. Dr. Levitt is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine.

Richards Afonja is a Hematologist and an Oncologist practicing medicine in Clifton, New Jersey. Dr. Afonja is rated as an Advanced provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Subacute Combined Degeneration, Vitamin B12 Deficiency, and Anemia.

Rumana Sultana is a Hematologist practicing medicine in Hazlet, New Jersey. Dr. Sultana is rated as an Advanced provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Hereditary Resistance to Anti-Vitamin K, and Bone Marrow Aspiration. Dr. Sultana is board certified in American Board Of Internal Medicine and Medical Oncology.

Joseph Ho is a Hematologist and an Oncologist practicing medicine in Plainsboro, New Jersey. He has been practicing medicine for over 10 years. Dr. Ho is rated as an Advanced provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Vitamin B12 Deficiency Anemia, Folate Deficiency, Multiple Carboxylase Deficiency, and Subacute Combined Degeneration. Dr. Ho is board certified in Hematology, 2023, Medical Oncology, 2023, and Internal Medicine, 2019. Dr. Ho is currently accepting new patients.

Dr. Emmanuel Apor's desire to take care of people channeled him into the field of medicine - specifically into cancer care. Board certified in internal medicine with fellowship training in hematology-oncology, Dr. Apor strives to first understand who his patients are as people, then learn about their disease.While attaining his bachelors of art degree at Rutgers University, Dr. Apor worked at a local hospital which cemented his decision to pursue postgraduate training. He achieved his medical degree at Drexel University College of Medicine in Philadelphia and his residency at the Warren Alpert Medical School at Brown University, where he developed a passion for clinical care working with his general internist mentors and their patients.Dr. Apor attained his fellowship training in hematology-oncology at Brown University, where he served in teaching and research roles, and he held hospital appointments at both Providence Veterans Affairs Medical Center and Rhode Island Hospital. Dr. Apor is rated as an Experienced provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Thrombocytopenia, Familial Colorectal Cancer, and Bone Marrow Aspiration. Dr. Apor is board certified in American Board Of Internal Medicine. Dr. Apor is currently accepting new patients.

Neil S. Nimkar, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in internal medicine, medical oncology and hematology by the American Board of Internal Medicine, he is trained in all malignancies and blood disorders. His clinical interests include anemia; hematology - WBC disorders; breast, colorectal, gastrointestinal, head and neck, and urological cancer (GU); leukemia and lymphoma. Dr. Nimkar strives to provide care individualized to the needs of each patient, while incorporating the most up-to-date knowledge and using precision medicine approach in treating patients. He takes pride in delivering the highest quality of patient care.After earning his medical degree at Ross University School of Medicine in Barbados, Dr. Nimkar completed his internal medicine residency at New York-Presbyterian Brooklyn Methodist Hospital in Brooklyn, NY, where he also performed his hematology-oncology fellowship. He received awards for excellence in clinical documentation as a best patient advocate, best ambulatory resident and as a wellness warrior. Dr. Nimkar joined ACOHA in 2021 following his fellowship training.In addition to English, Dr. Nimkar is fluent in Hindi and Gujarati. He has been published several times in peer-reviewed medical journals. His recent published research includes immunotherapy in hepatocellular cancer patients with mild to severe liver dysfunction, and he conducted an extensive study analyzing causes for the overtransfusion of blood products of patients. Dr. Nimkar is a participating provider of the Atlantic Accountable Care Organization. Dr. Nimkar is rated as an Experienced provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Melanoma. Dr. Nimkar is board certified in American Board Of Internal Medicine. Dr. Nimkar is currently accepting new patients.

Aileen Chen is a Hematologist and an Oncologist practicing medicine in Freehold Township, New Jersey. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. She is also highly rated in 32 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Chen is board certified in American Board Of Internal Medicine. Dr. Chen is currently accepting new patients.

Anthony Scarpaci is a Hematologist and an Oncologist practicing medicine in Sewell, New Jersey. Dr. Scarpaci is rated as an Experienced provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Sinus Cancer, Teratocarcinosarcoma, Olfactory Neuroblastoma, and Paget Disease of the Breast. Dr. Scarpaci is board certified in Medical Oncology, Internal Medicine, and Hematology. Dr. Scarpaci is currently accepting new patients.

Jason Levitz is a Hematologist and an Oncologist practicing medicine in Denville, New Jersey. Dr. Levitz is rated as an Experienced provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Colorectal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Levitz is board certified in American Board Of Internal Medicine. Dr. Levitz is currently accepting new patients.

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as an Experienced provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration. Dr. Scola is board certified in American Board Of Internal Medicine. Dr. Scola is currently accepting new patients.

Ashish Ashvin Shah, DO, MSc, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, he has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Shah’s clinical interests span a wide spectrum, from acute and chronic leukemia to lymphoma, multiple myeloma, myelodysplastic disease, and various types of cancer, including lung, colorectal, breast, ovarian, and neuroendocrine tumors. He has extensive knowledge and experience in these conditions.After earning his osteopathic medicine degree from Philadelphia College of Osteopathic Medicine, Dr. Shah completed an internal medicine residency at Robert Wood Johnson University Hospital in New Brunswick, NJ. He completed a hematology and oncology fellowship also at Robert Wood Johnson. Previously, he completed a Master of Science (MSc) degree in neuroscience at Southern Connecticut State University.Prior to joining AMG, Dr. Shah served as director of leukemia/lymphoma services and co-director of the adolescent and young adult oncology program at Lehigh Valley Health Network in Bethlehem, Pennsylvania for seven years. He also served as a clinical assistant professor of medicine at the University of South Florida’s Morsani College of Medicine in Tampa. Dr. Shah joined ACOHA in 2016.Dr. Shah is a member of the American Society of Clinical Oncology, American Society of Hematology, American Osteopathic Association, and American Association of Physicians from India. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Iron Deficiency Anemia, Large-Cell Immunoblastic Lymphoma, Childhood Iron Deficiency Anemia, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration. Dr. Shah is board certified in American Board Of Internal Medicine. Dr. Shah is currently accepting new patients.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Experienced provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Farber is board certified in American Board Of Internal Medicine. Dr. Farber is currently accepting new patients.

Ashish Khot, MD, is a fellowship-trained physician specializing in hematology/oncology with Atlantic Medical Group (AMG). Board-certified in hematology and medical oncology by the American Board of Internal Medicine, he has clinical expertise in diagnosing and treating blood disorders including anemia, leukemia, lymphoma and cancers of various organs, particularly lung, genitourinary, gastrointestinal and thoracic malignancies.Dr. Khot embraces a patient-centric approach, educating and empowering his patients and their families to make well-informed decisions regarding their health care. He strongly believes in fostering open communication among patients, their caregivers, and all collaborating physicians, ensuring that their care remains seamlessly coordinated throughout their challenging medical journeys.After earning his medical degree at Grant Medical College in Mumbai, India, Dr. Khot performed an internal medicine residency at St. Luke’s-Roosevelt Medical Center (now called Mt. Sinai West/Morningside) in New York City. He then received specialized training in a hematology and oncology fellowship at Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY.In addition to his clinical roles, Dr. Khot is the regional medical director, eastern region at Atlantic Medical Group, overseeing multiple subspecialist clinicians and pediatric practices. He is the associate medical director for GU oncology for community oncology given his special interest in genitourinary cancer. He is a national speaker on bladder and kidney cancers. He serves on several Atlantic Health System committees, including the Overlook Medical Center Blood Bank and Transfusion Committee, as well as the Union Essex Regional Council, AMG Nomination Committee and AMG Health Equity Committee. He regularly lectures and provides teaching rotations for IM and family medicine residents and medical students at Atlantic Health System hospitals.Dr. Ashish Khot is consistently recognized as a “Top Doctor” by New Jersey Monthly magazine by his peers. He is multilingual, speaking fluent Hindi and Marathi, among other languages. Dr. Khot is a participating provider of the Atlantic Accountable Care Organization. Dr. Khot is rated as an Experienced provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Anemia, Iron Deficiency Anemia, and Urothelial Cancer. Dr. Khot is board certified in American Board Of Internal Medicine. Dr. Khot is currently accepting new patients.

Joshua A. Strauss, MD, is a hematologist-oncologist with Advanced Care Oncology and Hematology Associates (ACOHA), part of the Atlantic Medical Group (AMG). He is fellowship-trained and double-board-certified in medical oncology and hematology by the American Board of Internal Medicine. He has more than 15 years of experience taking care of patients with a variety of malignancies and blood disorders. Dr. Strauss especially takes pride in treating his patients with compassion and going the extra mile to deliver the highest quality of care.Dr. Strauss strives to incorporate the most up-to-date knowledge in the field with an approach geared to the needs of each individual patient. He maintains clinical interests in gastrointestinal, urologic and gynecologic cancers, as well as leukemia, lymphoma and benign blood disorders. Dr. Strauss joined ACOHA in 2015.After earning his medical degree at the Albert Einstein College of Medicine in the Bronx, where he graduated with special distinction for research in medical oncology, Dr. Strauss completed his residency in internal medicine at New York University Langone Medical Center. He then completed fellowship training in hematology/oncology at New York-Presbyterian/Columbia University Medical Center, also in NYC, where he participated in high-level research and published several peer-reviewed articles in gastrointestinal cancer.Dr. Strauss has been voted by physician colleagues as a “Top Doctor” in New Jersey Monthly magazine every year since 2020. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Strauss is rated as an Experienced provider by MediFind in the treatment of Hereditary Resistance to Anti-Vitamin K. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Colorectal Cancer, and Bone Marrow Aspiration. Dr. Strauss is board certified in American Board Of Internal Medicine. Dr. Strauss is currently accepting new patients.